La distribución por tipo de cáncer fue: carcinoma papilar (87%), folicular (7,7%), anaplásico (3,5%) y medular (1,3%). El tratamiento primordial fue tiroidectomía. Descritores: Carcinoma anaplásico; Mutações; Novos agentes quimioterápicos .. In: Novelli JL, Sanchez A. Seguimiento en el cancer de tiroides. Rosario UNR . Descritores: Marcador biológico; Tiróide; Tumores de tiróide; Câncer de tiróide mutação de p53 em carcinoma anaplásico, rearranjo RET/PTC e de TRK-T em.

Author: Kigakree Tubar
Country: Japan
Language: English (Spanish)
Genre: Music
Published (Last): 24 January 2010
Pages: 113
PDF File Size: 6.8 Mb
ePub File Size: 11.28 Mb
ISBN: 600-4-45239-621-3
Downloads: 69095
Price: Free* [*Free Regsitration Required]
Uploader: Fenrishicage

Schlumberger M, Riroides F eds. Clin Cancer Res ;9: Clin Cancer Res ;2: None of the cases survived more than 1 year, and the median survival time was 3. Abnormalities of the EGF receptor system in human thyroid neoplasia. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Growth factors and goitrogenesis. Schmutzler C, Koehrle J. Curr Gene Cancer anaplasico de tiroides ;2: Frequent mutation and nuclear localization of b -catenin in anaplastic thyroid carcinoma.

Biological markers in thyroid tumors. In this review, we will discuss the main aspects of thyroid tumorigenesis and evaluate the potential of these factors cancer anaplasico de tiroides markers for thyroid follicular neoplasia.


403 Forbidden

Telomerase activity in benign and malignant thyroid tumors. Treatment of anaplastic thyroid carcinoma with paclitaxel: SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field. cancwr

Biochem Biophys Acta ; Nat Rev Mol Cell Biol ;4: In vivo sodium iodide symporter gene therapy of prostate cancer. J Endocrinol Invest ; Vogelstein B, Kinzler KW. Biotech Histochem ; Mol Endocrinol ; Canceer Rev ; High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. Advances in the cancer anaplasico de tiroides and management of thyroid neoplasms.

Houve toxicidade severa em metade dos pacientes. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues.

We now understand much of the alterations that occur in the expression of growth factors, receptors and the intracellular signaling pathway. Puente VerezC.

Management of undifferentiated thyroid cancer. However, none of these have yet proven to be efficient as a marker for diagnosis and prognosis, nor are they helpful in establishing a targeted therapeutic approach.

TRAP-silver staining, a highly sensitive assay for measuring telomerase activity in tumor tissue and cell lines. In contrast, anaplastic TC or undiferentiated TC, also derived from cancer anaplasico de tiroides thyroid follicular epithelium, refers to one of the more aggressive human malignancies, which have lost cancer anaplasico de tiroides or all characteristics of the tissue from which it originated. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.


Combination therapy for anaplastic giant-cell thyroid carcinoma. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-beta 1 TGF-beta tiroidfs.

Carcinoma papilar tiroideo asociado a linfoma. A propósito de tres casos – ScienceDirect

Acta Cancer anaplasico de tiroides Esp ; The thyrotropin receptor TSH-R is not an oncogene for thyroid tumors: The thyroid gland is extremely sensitive to external radiation. The best approach is still aggressive surgery combined with the associated use of new chemotherapies associated with local external beam radiotherapy. Papillary and follicular thyroid carcinoma.

Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.